Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanjing Li

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chemistry, an Asian Journal|January 24, 2026
Total Syntheses of Natural Polycyclic Sesterterpenoids With Anticancer BioactivitiesShaomin Fu, Bo Liu, Nanjing Li
BMC Pharmacology & Toxicology|March 28, 2023
Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathwayYou Zhang, Nanjing Li, He Li, et al.
Frontiers in Oncology|June 30, 2025
Comprehensive risk score of the E-PASS scoring system serves a prognostic indicator for patients after neoadjuvant therapy and curative esophageal cancer surgery: a multicenter retrospective studyNanjing Li, Yixin Liu, Jianfeng Zhou, et al.
Scientific Reports|July 2, 2025
Diminished angiogenic capacity in the hippocampus compared to the cortex indicates regional vulnerabilityXiaojie Li, Nanjing Li, Yao He, et al.
Biomacromolecules|August 1, 2025
Hierarchical Nanocellulose-Based Functional Films: A Sustainable and High-Performance Alternative to Conventional Plastic FilmsXinyuan Wan, Nanjing Li, Jiemin Qiu, et al.
Biochemical Pharmacology|February 4, 2024
WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with StathminJun Yang, Nanjing Li, Xinyu Zhao, et al.
Science China. Life Sciences|March 23, 2026
Blood and lymphatic vascular network in bone injury repair: from molecular mechanisms to therapeutic strategiesMinghan Ye, Nanjing Li, He Cai, et al.
The American Journal of Surgical Pathology|April 24, 2026
Whole-Exome Sequencing Identifies Frequent AHNAK2 Mutations With Prognostic Significance in Undifferentiated Primary Liver CarcinomaZiqi Zhu, Qing Tao, Liangyin Chen, et al.
Cancers|April 14, 2026
LPCAT1 and MRPL9 Promote Hepatocellular Carcinoma Progression via AKT Phosphorylation and Define a Mitochondrial Prognostic ModelHui Yang, Ziqi Zhu, Hanwen Zhu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 19, 2022
PUMA overexpression dissociates thioredoxin from ASK1 to activate the JNK/BCL-2/BCL-XL pathway augmenting apoptosis in ovarian cancerYang Chen, Nanjing Li, Jun Yang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chemistry, an Asian Journal|January 24, 2026
Total Syntheses of Natural Polycyclic Sesterterpenoids With Anticancer BioactivitiesShaomin Fu, Bo Liu, Nanjing Li
BMC Pharmacology & Toxicology|March 28, 2023
Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathwayYou Zhang, Nanjing Li, He Li, et al.
Frontiers in Oncology|June 30, 2025
Comprehensive risk score of the E-PASS scoring system serves a prognostic indicator for patients after neoadjuvant therapy and curative esophageal cancer surgery: a multicenter retrospective studyNanjing Li, Yixin Liu, Jianfeng Zhou, et al.
Scientific Reports|July 2, 2025
Diminished angiogenic capacity in the hippocampus compared to the cortex indicates regional vulnerabilityXiaojie Li, Nanjing Li, Yao He, et al.
Biomacromolecules|August 1, 2025
Hierarchical Nanocellulose-Based Functional Films: A Sustainable and High-Performance Alternative to Conventional Plastic FilmsXinyuan Wan, Nanjing Li, Jiemin Qiu, et al.
Biochemical Pharmacology|February 4, 2024
WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with StathminJun Yang, Nanjing Li, Xinyu Zhao, et al.
Science China. Life Sciences|March 23, 2026
Blood and lymphatic vascular network in bone injury repair: from molecular mechanisms to therapeutic strategiesMinghan Ye, Nanjing Li, He Cai, et al.
The American Journal of Surgical Pathology|April 24, 2026
Whole-Exome Sequencing Identifies Frequent AHNAK2 Mutations With Prognostic Significance in Undifferentiated Primary Liver CarcinomaZiqi Zhu, Qing Tao, Liangyin Chen, et al.
Cancers|April 14, 2026
LPCAT1 and MRPL9 Promote Hepatocellular Carcinoma Progression via AKT Phosphorylation and Define a Mitochondrial Prognostic ModelHui Yang, Ziqi Zhu, Hanwen Zhu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 19, 2022
PUMA overexpression dissociates thioredoxin from ASK1 to activate the JNK/BCL-2/BCL-XL pathway augmenting apoptosis in ovarian cancerYang Chen, Nanjing Li, Jun Yang, et al.
Pageof 2